Combining vascular and trophic biomarkers (netrin-1, omentin-1, and circRNAs) with injury markers (NfL) and oxidative stress indicators (thioredoxin and bilirubin) moves stroke assessment beyond lesion quantification to evaluating repair capacity and systemic resilience [65,66,67]. The gene discussed is NEFL; the disease is stroke disorder.